Cargando…
Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
AIMS: The study investigates the effectiveness and safety of methotrexate (MTX) versus leflunomide (LEF) in 12-month treatment of Takayasu arteritis (TAK). METHODS: This was a cohort study. Patients diagnosed with TAK between 1 January 2013 and 1 January 2019 were enrolled from First Hospital of Chi...
Autores principales: | Wu, Chunling, Sun, Ying, Cui, Xiaomeng, Wu, Sifan, Ma, Lili, Chen, Huiyong, Yan, Yan, Ji, Zongfei, Liu, Yun, Lin, Jiang, Lv, Peng, Chen, Rongyi, Yang, Pingting, Jiang, Lindi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705767/ https://www.ncbi.nlm.nih.gov/pubmed/33294149 http://dx.doi.org/10.1177/2040622320975233 |
Ejemplares similares
-
Efficacy and safety of leflunomide versus cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
por: Ying, Sun, et al.
Publicado: (2020) -
Involvement of the pulmonary arteries in patients with Takayasu arteritis: a prospective study from a single centre in China
por: Kong, Xiufang, et al.
Publicado: (2020) -
Clinical characteristics, imaging phenotypes and events free survival in Takayasu arteritis patients with hypertension
por: Ying, Sun, et al.
Publicado: (2021) -
Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis
por: Chen, Rongyi, et al.
Publicado: (2021) -
Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study
por: Dai, Xiaomin, et al.
Publicado: (2020)